The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities
|一次細胞・幹細胞由来細胞市場：現在および将来の機会 The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities|
|出版日: 2013年05月17日||ページ情報: 英文||
With barriers to entry low, the number of companies supplying high quality human tissue for research continues to rise. At the same time, the range of cell types available has also expanded to include more specialized normal cell types as well as cells isolated from non-normal or disease-state tissues. Many primary cell suppliers have also commercialized various types of multipotent stem cells, also called adult stem cells. Like other primary cells, adult stem cells have a fi nite number of population doublings in vitro. Depending on the cell type used, primary cells and adult stem cells are used in a wide variety of research applications: from basic or discovery research, to drug discovery and development; from ADME/Toxicology screening to regenerative medicine and in vitro tissue models.
In The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities, BioInformatics LLC takes the pulse of this dynamic market. This study seeks to identify where primary cells and primary cell suppliers fi t in the universe of cells used in in vitro systems, whether or not the use of primary cells is increasing or decreasing, what cell types are used most often, how satisfi ed scientists are with commercially available primary cells, and what is the market size and anticipated growth rate.
Pluripotent stem cells-those capable of differentiating into any cell type-have captured the imagination of scientists across many disciplines. As cell culture know-how has evolved, better and more reproducible conditions for maintaining these cells in their pluripotent state have been developed. Concomitant with optimizing cell culture conditions to maintain pluripotency have been efforts to optimize the in vitro environment to induce differentiation to create populations of highly pure and rigorously characterized differentiated cell types, including neurons, cardiomyocytes and hepatocytes.
Because terminally differentiated cells can be used in many applications where primary cells are currently employed and because the concept is relatively new, suppliers are asking multiple questions about this technology. Are researchers responding to the availability of this new source of cells? How many? What cell types are important? Where are they obtained? How will the use of primary cells be affected by the availability of stem cell-derived differentiated cell types? The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities profi les this emerging market and the role of commercial suppliers in this area.
This study of the academic and pharma/biotech sectors in North America and Europe will provide an analysis of the market for primary cells and an assessment of the brand equity for the leading companies who serve this market. This report will also describe the emerging market for stem cell-derived differentiated cells-a potential threat (or opportunity) for this market.
This study will explore the following market analytics:
This study will explore the following product analytics:
This study will explore the following brand analytics:
The Market for Primary Cells & Stem-Cell Derived Cells: Current and Future Opportunities, is based on responses to a 43-question online survey for life scientists conducted by BioInformatics, LLC (Arlington, Virginia, USA). 894 life scientists participated in the survey between March 20 and April 9, 2013.
The electronic questionnaire was fi elded to registered members of The Science Advisory Board®. BioInformatics sponsors The Science Advisory Board, an online community of over 72,000 scientists, physicians and healthcare professionals from around the world.
The Science Advisory Board is divided into two panels Research and Clinical) and "convenes" regularly via Internet (scienceboard.net) to voice their opinions on a wide variety of issues relating to biomedical research and clinical technologies. These experts - representing all aspects of the life sciences and medicine - have agreed to make themselves available to participate in our online research activities. The Science Advisory Board members who participated in this study were drawn from the Board's Research Panel.
Unlike reports from other firms that are based on an analyst's subjective summary of information from publicly available sources, our reports are based on the results of detailed surveys of hundreds - even thousands - of scientific and medical professionals who buy your products.
Our questionnaires are developed by a multi-disciplinary team of scientists, industry veterans and market research experts with years of experience. These professionals understand that survey questions need to be asked in a way that ensures the answers will directly address the business challenges you face. Once the survey data is collected, this same team creates a unique report that presents the reader with a thorough understanding of the topic and the scientific and business implications of the results based on sophisticated statistical analytics.
If you'd like to delve deeper into the data from a study, we can always perform custom cross-tabulations or other analysis on your behalf. We can even pose follow-up questions to respondents who answered in a particular way or conduct a custom study to extend your knowledge.
When others promote results from their online surveys, they fail to mention the uncontrolled nature of their broadcast email invitations. To provide you with the most valid and accurate results possible, the respondents to our surveys are members of our unique online panel - The Science Advisory Board®. - which consists of almost 72,000 verified life science and biomedical professionals who have agreed to take part in our surveys, focus groups and other market research activities. These respondents are carefully selected based on their professional qualifications, market segments and geographic regions - we can even select them based on the products they use and their preferred suppliers.
With your purchase, we offer one free hour of consultation with our talented team of scientific and business analysts who created the report. During this consultation, we can answer any questions you may have about the survey results and what we believe to be the significant trends affecting the market.